Accelerate machine learning on enterprise-wide platforms

The Food and Drug Administration (FDA) protects public health by ensuring the safety, efficacy, and security of our nation’s biological products, drugs, medical devices, and food supply. With the ever-growing number of regulatory review submissions, the FDA needs a smarter process to complete reviews on time with limited resources. In this breakout session, learn how Amazon artificial intelligence (AI) and machine learning (ML) services enable the FDA to accelerate the development time, shorten the runway to production, and eliminate tedious manual reviews